ArticleFrontiers in surgery2025
Seroma formation after parotidectomy: incidence, risk factors, and clinical implication.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Innovative photobiomodulation-enhanced T-PRF in posterior mandibular fractures: a randomized pilot study.BMC oral health · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative seroma is an underrecognized but clinically relevant complication after parotidectomy, leading to repeated aspirations and patient discomfort. Limited evidence exists on its incidence, risk factors, and clinical course. Methods: We retrospectively reviewed 527 patients who underwent parotidectomy between 2020 and 2025. Demographics, tumor characteristics, surgical details, and postoperative variables were analyzed. Seroma was defined as fluid accumulation requiring aspiration without evidence of salivary fistula. Persistent seroma was defined as requiring multiple aspirations or persisting beyond 14 days after drain removal. Multivariate logistic regression was performed to identify independent predictors, and subgroup analyses were conducted for persistent seroma. Results: Seroma occurred in 10.6% of patients. Independent risk factors included anterior tumor location (OR 2.21), larger tumor size (OR 1.58 per cm), body mass index ≥25 (OR 1.76), and use of facelift-type incisions (OR 1.92). Among patients with seroma, 33.9% developed persistent seroma, which was associated with larger tumors, higher BMI, greater aspirated volumes, and longer resolution times. Higher drain output prior to removal was also observed in the seroma group, suggesting that current thresholds for drain removal may be insufficient in high-risk patients. Conclusion: Anterior tumor location, larger tumor size, elevated body mass index, and facelift-type incisions are significant predictors of postoperative seroma after parotidectomy. Risk-adapted strategies, such as individualized drain removal protocols and early use of compression dressings, may reduce seroma-related morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.